Skip to main content
Premium Trial:

Request an Annual Quote

Caris Life Sciences to Offer Molecular Profiling Services on Flatiron Health Platform

NEW YORK — Caris Life Sciences said on Friday that it has struck a deal to integrate its molecular profiling offerings into Flatiron Health's cloud-based OncoEMR platform for electronic health record management.

Irving, Texas-based Caris offers a range of molecular profiling services, which analyze DNA, RNA, and protein biomarkers to aid in cancer detection, diagnosis, monitoring, and therapy selection. Through the deal, these services will be available for order within OncoEMR, which is used by over 2,000 clinicians at more than 800 cancer care locations throughout the US, Caris said.

Financial and other terms were not disclosed.

"This molecular profiling integration with Caris allows oncologists and their teams to efficiently order molecular profiling tests, track order status, and view results, all without leaving OncoEMR," James Hamrick, VP of clinical oncology at Flatiron, said in a statement.

Caris President and CSO David Spetzler added, "Delivering critical molecular results directly at the point of care in community oncology settings is paramount to every patient's ability to fight, and hopefully beat, cancer."

About a year ago, Foundation Medicine signed an agreement with New York City-based Flatiron to offering its comprehensive genomic profiling tests through OncoEMR. Both firms are part of Roche.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.